Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2000-7-6
pubmed:abstractText
Low-grade intraosseous osteosarcoma is an uncommon form of bone cancer. It is occasionally difficult to recognize as a malignant tumor and is commonly misdiagnosed as a benign fibrous lesion. We retrospectively studied the records of 8 patients with low-grade intraosseous osteosarcoma in the files of the Tohoku Musculoskeletal Tumor Society in Japan. All tumors arose in the lower limb. The most common symptom was pain, with a duration exceeding 2 years in 4 patients. Radiologic findings, including those at magnetic resonance imaging (MRI), suggested malignancy in 5 lesions, whereas 3 were diagnosed as benign. Two patients initially presented with pathological fracture. The initial pathological diagnosis was malignant in 5 patients and benign in 3. All eight tumors were grade 1 in Broders' classification. The tumor showed a permeative pattern in all eight cases, but this pattern could not be confirmed in the multiple tiny fragments obtained as biopsy specimens in 3 cases. The number of silver-staining nucleolar organizer regions (AgNOR) per nucleus and MIB-1-positive rate were significantly higher in low-grade intraosseous osteosarcoma than in fibrous dysplasia, offering an advantage in differential diagnosis. Three patients (38%) developed high-grade sarcoma at the site of local recurrence after multiple intralesional excisions, and one of them died of the disease. The other 5 patients had a good clinical course after surgery with a wide margin. These findings indicate that preoperative diagnosis with radiologic investigation, including magnetic resonance (MR) imaging and histologic examination of biopsy specimens is essential in preparation for surgery with a wide margin, assuring a good clinical course, and the results of AgNOR and immunohistochemical MIB-1 staining might be helpful in differentiating low-grade intraosseous osteosarcoma from fibrous dysplasia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0046-8177
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
633-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10872654-Adolescent, pubmed-meshheading:10872654-Adult, pubmed-meshheading:10872654-Aged, pubmed-meshheading:10872654-Antigens, Nuclear, pubmed-meshheading:10872654-Bone Neoplasms, pubmed-meshheading:10872654-Combined Modality Therapy, pubmed-meshheading:10872654-Diagnosis, Differential, pubmed-meshheading:10872654-Female, pubmed-meshheading:10872654-Femoral Neoplasms, pubmed-meshheading:10872654-Humans, pubmed-meshheading:10872654-Immunohistochemistry, pubmed-meshheading:10872654-Japan, pubmed-meshheading:10872654-Ki-67 Antigen, pubmed-meshheading:10872654-Male, pubmed-meshheading:10872654-Middle Aged, pubmed-meshheading:10872654-Nuclear Proteins, pubmed-meshheading:10872654-Nucleolus Organizer Region, pubmed-meshheading:10872654-Osteosarcoma, pubmed-meshheading:10872654-Silver Staining
pubmed:year
2000
pubmed:articleTitle
Low-grade intraosseous osteosarcoma in northern Japan: advantage of AgNOR and MIB-1 staining in differential diagnosis.
pubmed:affiliation
Tohoku Musculoskeletal Tumor Society, Akita University School of Medicine, Japan.
pubmed:publicationType
Journal Article